Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows

Benzinga
Benzinga
  • 2 months ago
Eli Lilly has come out on top in a weight loss drug competition in a recent study. The study found that patients on Lilly’s Mounjaro lost more weight than those on Novo Nordisk’s Ozempic.

Recommended

0:41
I
Up next
Exxon Mobil Predicts Fossil Fuels Will Dominate Energy Mix Until 2050, Warns Halting Investment Could Lead to Energy Crisis
Benzinga
0:43
Ozempic Weight Loss Drug Maker Is Making Money Hand Over Fist - And Just Raised Its Profit Forecast
Benzinga
1:00
Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
Benzinga
1:16
Ozempic Effect: Food Industry Feels The Heat As Weight-Loss Drugs Get Popular, Investors Call For Menu Makeovers
Benzinga
1:19
Oprah Winfrey Tackles Weight Loss Drug Stigma In Prime-Time Special Amid Wegovy-Ozempic Frenzy: 'For 25 Years, Making Fun Of My Weight Was National Sport'
Benzinga
0:36
Pharma Bro Martin Shkreli Ordered to Surrender Rare Wu-Tang Clan Album Copies Amid Legal Battle
Benzinga
0:34
Temu Parent PDD Holdings Plummets Nearly 30% After Disappointing Q2 Results. Analyst Says, 'Panic Was Overblown' and May Present a Promising Investment Opportunity
Benzinga
0:32
Nvidia Partner Sustainable Metal Cloud Is Capitalizing on AI Demand with Energy-Efficient Cooling Centers That Reduce Consumption by 50%
Benzinga
1:17
Donald Trump Unveils New NFT Collection Featuring Debate Memorabilia And Exclusive Perks
Benzinga
1:04
Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'
Benzinga
1:09
Ozempic Maker's Parent Company To Invest $7B Annually By 2030: 'We Have More Money Than Ever To Invest'
Benzinga
1:01
Cathie Wood's Ark Invest Snaps Up $3.54M Worth Of Shares In This Biopharma Company Following Positive Obesity Pipeline Update
Benzinga
3:04
How End Of Month Buy And Sell Imbalances Effected Stock Movements
Benzinga
1:00
Levi Strauss Analysts Boost Their Forecasts After Upbeat Earnings
Benzinga
0:34
CrowdStrike Stock Is Sliding Tuesday: What's Going On?
Benzinga
4:07
Nike Q1 Earnings Highlights: EPS Beats As North American Sales Slide, Shares Move Higher
Benzinga
1:07
Jim Cramer Stands By Nvidia And Eli Lilly Despite Market Dips, Says 'Terrific Time To Take Some Profits'
Benzinga
1:45
Are Housing Stocks Pointing Towards A Recession? - $TOL
Benzinga
2:34
Disaster Stock Of The Day: Why Dick's Sporting Goods Shares Are Diving Today $DKS
Benzinga
0:39
Two Top Executives Resign as Investigation Links Deaths to Kobayashi Pharmaceutical's Rice Products
Benzinga
15:51
Dee Choubey, Co-Founder and CEO of MoneyLion - $ML
Benzinga
1:08
As Global Markets Roil, Strategist Soothes Nerves: 'Some Normal Action Under The Surface' As 'Tech Got Way Ahead Of Itself'
Benzinga
0:58
Charlie Munger Revealed What Was Left On His Bucket List Before He Died
Benzinga
2:29
The Yen Carry Trade: Is The Worst Behind Us?
Benzinga
4:15
Go Woke, Go Broke, ETF and GUNZ ETF, Matthew Tuttle, Tuttle Capital Management
Benzinga